Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor.

× No keyword cloud information.

11 in total

1. Case of the month: rivastigmine (Exelon) toxicity with evidence of respiratory depression.

Authors: S Sener; M Ozsarac
Journal: Emerg Med J Date: 2006-01 Impact factor: 2.740

2. Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size.

Authors: Kunisi S Venkatasubban; Joseph L Johnson; Jamie L Thomas; Abdul Fauq; Bernadette Cusack; Terrone L Rosenberry
Journal: Arch Biochem Biophys Date: 2018-08-09 Impact factor: 4.013

3. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.

Authors: W Sippl; J M Contreras; I Parrot; Y M Rival; C G Wermuth
Journal: J Comput Aided Mol Des Date: 2001-05 Impact factor: 3.686

Review 4. Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Authors: Krista L Lanctôt; Nathan Herrmann; Maysoon M LouLou
Journal: J Psychiatry Neurosci Date: 2003-01 Impact factor: 6.186

5. Investigation of the binding mode of (-)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method.

Authors: Qiong Xie; Yun Tang; Wei Li; Xing-Hai Wang; Zhui-Bai Qiu
Journal: J Mol Model Date: 2006-01-11 Impact factor: 1.810

Review 6. Rivastigmine. A review of its use in Alzheimer's disease.

Authors: C M Spencer; S Noble
Journal: Drugs Aging Date: 1998-11 Impact factor: 3.923

Review 7. Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.

Authors: Muriel Noetzli; Chin B Eap
Journal: Clin Pharmacokinet Date: 2013-04 Impact factor: 6.447

Review 8. Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.

Authors: C Sadowsky; J A Davila Perez; R W Bouchard; I Goodman; S Tekin
Journal: CNS Neurosci Ther Date: 2010 Impact factor: 5.243

9. Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations.

Authors: Nazish U Tanoli; Sheraz A K Tanoli; Antonio G Ferreira; Mazhar Mehmood; Sana Gul; Julia L Monteiro; Lucas C C Vieira; Tiago Venâncio; Arlene G Correa; Zaheer Ul-Haq
Journal: J Mol Model Date: 2018-07-14 Impact factor: 1.810

10. Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.

Authors: George T Grossberg
Journal: Curr Ther Res Clin Exp Date: 2003-04